Jessica Meng
Förmögenhet: 8 M $ per 2026-08-31
Förmögenhet: 8 M $ per 2026-08-31
Jessica Meng is Chief Commercial Officer at CareDx, Inc. since 2024.
Former roles include Vice President-Marketing at Veracyte, Inc. from 2018 to 2020 and Chief Commercial Officer at Delfi Diagnostics, Inc. Education includes an undergraduate degree from the University of Pennsylvania and an MBA from The Wharton School of the University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CAREDX, INC. 0,31 % | 2026-09-12 | 161 599 ( 0,31 % ) | 8 M $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| CAREDX, INC. | Företagsledare/Principal | 2024-09-12 |
| Företag | Position | Slut |
|---|---|---|
| VERACYTE, INC. | Försäljning & Marknadsföring | 2020-05-01 |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
CareDx, Inc.
CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
Veracyte, Inc.
Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delfi Diagnostics, Inc.
Delfi Diagnostics, Inc. BiotechnologyHealth Technology Develops AI-powered liquid biopsy tests using fragment omics technology to help detect cancer early through simple blood draws | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån